Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

Q: What does CUSIP 98943L107 represent in this 13F holders report?

CUSIP 98943L107 is the security identifier for ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share in Q1 2024?

140 institutional investors reported ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share for Q1 2024. Use the holders table for investor-level position and value details.

CUSIP: 98943L107

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock,$0.001 par value per share
Shares outstanding: 72,096,078
Total 13F shares: 85,290,558
Share change: +4,205,796
Total reported value: $1,344,227,610
Put/Call ratio: 3.4%
Reported price per share: $15.76
Number of holders: 140
Value change: +$67,005,140
Number of buys: 75
Number of sells: 49

Security key

98943L107

Report period

Q1 2024

Institutions

140

Top holders

ZNTL full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2024 Previous quarter: Q4 2023 Zentalis Pharmaceuticals, Inc. SEC filings Zentalis Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 98943L107

Newer quarter: Q2 2024 Previous quarter: Q4 2023

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Matrix Capital Management...

13D/G signal

—

Evidence rows

Latest as of

31 Dec 2023

13F Lead comparable stake: 19% Showing 1-6 of 15 holder rows.

Rank 1 holder

Matrix Capital Management Company, LP

13F

Ownership: 19%
Position: $211.49M

13F

Rank 2 holder

EVENTIDE ASSET MANAGEMENT, LLC

13F

Ownership: 16%
Position: $175.13M

13F

Rank 3 holder

FMR LLC

13F

Ownership: 14%
Position: $156.61M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Matrix Capital Management Company, LP	13F Company 13F	19%	$211,493,591 13,959,973 shares	—	31 Dec 2023
EVENTIDE ASSET MANAGEMENT, LLC	13F Company 13F	16%	$175,133,621 11,559,975 shares	—	31 Dec 2023
FMR LLC	13F Company 13F	14%	$156,605,110 10,336,971 shares	—	31 Dec 2023
VANGUARD GROUP INC	13F Company 13F	7.4%	$81,059,439 5,350,458 shares	—	31 Dec 2023
BlackRock Finance, Inc.	13F Company 13F	6.5%	$70,977,371 4,684,975 shares	—	31 Dec 2023
STATE STREET CORP	13F Company 13F	6.1%	$66,918,398 4,417,056 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

140

85,290,558

Rows available

140

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

118

Q1 2024 holders

140

Holder diff

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 value	Q1 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend